Griscelli syndrome (GS) is a rare autosomal recessive disorder, characterized by pigmentary dilution of the skin and hair and in most patients by abnormal regulation of the immune system, which results in a syndrome of macrophage hyperactivation, known as hemophagocytic lymophohistiocytosis (HLH). Allogeneic hematopoietic stem cell transplantation (HSCT) is the only curative treatment available for genetically induced HLH. Few cases of successful HSCT from a compatible donor have been reported in children with GS. We describe the first patient with GS cured with an allograft from a compatible unrelated bone marrow donor. We used a novel preparative regimen consisting of busulfan, thiotepa and fludarabine. The demonstrated curative effect of HSCT from an unrelated donor in a patient with genetically determined HLH also supports the use of a systematic diagnostic approach in these patients, in order to identify those with a worse prognosis and needing an urgent allograft in a timely manner.

Aricò, M., Zecca, M., Santoro, N., Caselli, D., Maccario, R., Danesino, C., De Saint Basile, G., Locatelli, F., Successful treatment of Griscelli syndrome with unrelated donor allogeneic hematopoietic stem cell transplantation, <<BONE MARROW TRANSPLANTATION>>, 2002; 29 (12): 995-998. [doi:10.1038/sj.bmt.1703567] [https://hdl.handle.net/10807/262454]

Successful treatment of Griscelli syndrome with unrelated donor allogeneic hematopoietic stem cell transplantation

Locatelli, Franco
2002

Abstract

Griscelli syndrome (GS) is a rare autosomal recessive disorder, characterized by pigmentary dilution of the skin and hair and in most patients by abnormal regulation of the immune system, which results in a syndrome of macrophage hyperactivation, known as hemophagocytic lymophohistiocytosis (HLH). Allogeneic hematopoietic stem cell transplantation (HSCT) is the only curative treatment available for genetically induced HLH. Few cases of successful HSCT from a compatible donor have been reported in children with GS. We describe the first patient with GS cured with an allograft from a compatible unrelated bone marrow donor. We used a novel preparative regimen consisting of busulfan, thiotepa and fludarabine. The demonstrated curative effect of HSCT from an unrelated donor in a patient with genetically determined HLH also supports the use of a systematic diagnostic approach in these patients, in order to identify those with a worse prognosis and needing an urgent allograft in a timely manner.
2002
Inglese
Aricò, M., Zecca, M., Santoro, N., Caselli, D., Maccario, R., Danesino, C., De Saint Basile, G., Locatelli, F., Successful treatment of Griscelli syndrome with unrelated donor allogeneic hematopoietic stem cell transplantation, <<BONE MARROW TRANSPLANTATION>>, 2002; 29 (12): 995-998. [doi:10.1038/sj.bmt.1703567] [https://hdl.handle.net/10807/262454]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/262454
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 37
  • ???jsp.display-item.citation.isi??? 29
social impact